Options Data for US Stocks: End-of-Day and Historical Learn more

Xilio Development Inc icon

Xilio Development Inc (XLO NASDAQ) stock market data APIs

$7.6287 0.21(2.8%)
as of November 18, 2026
Try our APIs with free plan!

Xilio Development Inc Financial Data Overview

Price chart is built with Anychart

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.

Prev. Close 7.6287
Open 7.8407
High 7.884
Low 7.3192
52 wk Range 6.468-11.2
Market Cap 53 333 K
P/E Ratio 11.6154
Shares Outstanding 7 064 K
Revenue 55 010 K
EPS -0.54
Beta -0.113

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Xilio Development Inc (top by weight)

Ticker
100-day Price Change
Weight
IWC.US iShares Micro-Cap ETF
-29.74 (-15.12%)
0.01
VXF.US Vanguard Extended Market Index Fund ETF Shares
-22.8 (-9.27%)
0.00
DCOR.US DFA Investment Dimensions Group Inc.
-4.06 (-4.78%)
0.00
VTI.US Vanguard Total Stock Market Index Fund ETF Shares
-21.19 (-5.57%)
0.00
DFAC.US DFA Investment Dimensions Group Inc.
-2.38 (-5.2%)
0.00

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Xilio Development Inc data using free add-ons & libraries


Get Xilio Development Inc Fundamental Data

Xilio Development Inc logo

Xilio Development Inc Fundamental data includes:

  • Net Revenue: 55 010 K
  • EBITDA: -39 869 000
  • Earnings Per Share: 0
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Xilio Development Inc Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-11-10
  • EPS/Forecast: -1.05
GET THE PACKAGE

Get Xilio Development Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Xilio Development Inc News

Get Xilio Development Inc fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE

Send the request

Leave your email and our team will contact you ASAP.